Although different results have been achieved depending on combinations, other peptide-based vaccines have also led to pancreatic cancer patients inducing an antibody response but without achieving impressive results; these include the MUC1 vaccines [116], anti-VEGFR vaccines [117,118], survivin [119], anti-gastrin [120], anti-heat shock protein vaccine [121], and anti-WT-1 [122]. Here, MUC1 is linked to pancreatic neoplasm.